383 related articles for article (PubMed ID: 18097543)
21. CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.
Biasoli I; Morais JC; Scheliga A; Milito CB; Romano S; Land M; Pulcheri W; Spector N
Histopathology; 2005 Mar; 46(3):328-33. PubMed ID: 15720419
[TBL] [Abstract][Full Text] [Related]
22. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
23. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.
Shinohara ET; Gonzalez A; Massion PP; Chen H; Li M; Freyer AS; Olson SJ; Andersen JJ; Shyr Y; Carbone DP; Johnson DH; Hallahan DE; Lu B
Cancer; 2005 Apr; 103(8):1685-92. PubMed ID: 15742356
[TBL] [Abstract][Full Text] [Related]
24. Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions.
Falleni M; Pellegrini C; Marchetti A; Roncalli M; Nosotti M; Palleschi A; Santambrogio L; Coggi G; Bosari S
Lung Cancer; 2005 May; 48(2):211-6. PubMed ID: 15829320
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma.
Pedersen LM; Jürgensen GW; Johnsen HE
Br J Haematol; 2005 Mar; 128(6):813-9. PubMed ID: 15755285
[TBL] [Abstract][Full Text] [Related]
27. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
28. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
[TBL] [Abstract][Full Text] [Related]
29. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
[TBL] [Abstract][Full Text] [Related]
30. Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study.
Marioni G; Staffieri A; Lionello M; Tealdo G; Staffieri C; Giacomelli L; Friso ML; Stramare R; Ottaviano G; Blandamura S
J Oral Pathol Med; 2013 Apr; 42(4):339-44. PubMed ID: 23126236
[TBL] [Abstract][Full Text] [Related]
31. Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome.
Byun SS; Yeo WG; Lee SE; Lee E
Urology; 2007 Jan; 69(1):34-7. PubMed ID: 17270609
[TBL] [Abstract][Full Text] [Related]
32. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.
Kappler M; Kotzsch M; Bartel F; Füssel S; Lautenschläger C; Schmidt U; Würl P; Bache M; Schmidt H; Taubert H; Meye A
Clin Cancer Res; 2003 Mar; 9(3):1098-104. PubMed ID: 12631613
[TBL] [Abstract][Full Text] [Related]
33. Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma.
Preuss SF; Weinell A; Molitor M; Semrau R; Stenner M; Drebber U; Wedemeyer I; Hoffmann TK; Guntinas-Lichius O; Klussmann JP
Head Neck; 2008 Oct; 30(10):1318-24. PubMed ID: 18704972
[TBL] [Abstract][Full Text] [Related]
34. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
Yagihashi A; Ohmura T; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Hirata K; Watanabe N
Clin Chim Acta; 2005 Dec; 362(1-2):125-30. PubMed ID: 16026775
[TBL] [Abstract][Full Text] [Related]
35. Survivin expression and its clinical significance in pancreatic cancer.
Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
[TBL] [Abstract][Full Text] [Related]
36. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
[TBL] [Abstract][Full Text] [Related]
37. High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma.
Marioni G; Ottaviano G; Marchese-Ragona R; Giacomelli L; Bertolin A; Zanon D; Marino F; Staffieri A
Acta Otolaryngol; 2006 Feb; 126(2):197-203. PubMed ID: 16428200
[TBL] [Abstract][Full Text] [Related]
38. Survivin expression predicts early recurrence in early-stage breast cancer.
Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
[TBL] [Abstract][Full Text] [Related]
39. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]